vendredi 21 septembre 2012

Press Review (September 22, 2012) – Revue de presse (22 septembre 2012)





Poor Pain Control for Cancer Patients
Recounting her father’s struggle with cancer was difficult for the young woman, even several years after his death. He’d endured first surgery and then chemotherapy and radiation, she told me, and the cancer had gone into remission. He was thrilled, but the aggressive treatment left him with chronic, debilitating pain. Once active, he struggled to get around in his own home. “It wasn’t the cancer that got him,” the daughter said. “It was the pain.”
By Pauline W. Chen. In The New York Times (blog)

Smoking and Drinking Linked to Earlier Pancreatic Cancer
People who smoke or drink heavily may develop pancreatic cancer at a younger age than those who don't, according to a recent study of 811 pancreatic cancer patients.
By Jaimie Dalessio. In Huffington Post

Least Aggressive Breast Cancer Still Poses Long-Term Risk, Study Finds
Women with common tumor types might die of disease a decade later, affecting treatment decisions.
In U.S. News & World Report

Cancer surpasses heart disease as cause of death among Hispanics‎‎
Cancer is now the leading cause of death among Hispanics in the United States, surpassing deaths due to heart disease, researchers reported Monday.
By Michael Muskal. In Los Angeles Times

Merck KGaA pulls second lung cancer drug filing‎
German drugmaker Merck KGaA has withdrawn its second attempt to win European approval for use of its Erbitux drug against lung cancer, capping a string of setbacks in its drug development.
In Reuters

Quality-of-life program may help cancer patients
A therapy program focused on improving quality of life can help people being treated for advanced cancer, researchers from the Mayo Clinic in Rochester, Minnesota, have found.
In Reuters



Cancer de la prostate : le traitement Zytiga confirme son efficacité
Une étude internationale publiée mardi indique qu'une nouvelle molécule connue sous le nom de Zytiga et composée d'acétate d'abiratérone aurait la propriété d'améliorer la qualité de vie de patients atteints de cancer avancé de la prostate.
Dans Maxisciences

Cancer du sein : les limites du dépistage‎‎
Près de 20 % de cancers pourraient survenir dans l'intervalle entre deux dépistages organisés, affirment des spécialistes.
Dans Le Point

Cancers : que faire si l'on vient d'une famille à risques ?‎‎
Les consultations oncogénétiques, comme celles en pré et en postnatal, s'adressent à des personnes bien ciblées.
Par Nathalie Szapiro-Manoukian. Dans Le Figaro

Le sel favoriserait le cancer de l'estomac‎
Limiter sa consommation de sel est bénéfique non seulement au chapitre de la pression artérielle, mais aussi du cancer de l’estomac..
Par Marie-Claude Ouellet. Dans Agence Science-Presse


Aucun commentaire:

Enregistrer un commentaire